Search
forResearch 10 of 1000+
- Three-Month Treatment With a Long-Acting Gonadotropin-Releasing Hormone Agonist of Patients With Benign Prostatic Hyperplasia: Effects on Tissue Androgen Concentration, 5<i>α</i>-Reductase Activity and Androgen Receptor Content*
- A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome
- Dissolving microneedle patch loading dutasteride microspheres for the long-acting treatment of androgenetic alopecia
- Investigation, treatment and monitoring of late‐onset hypogonadism in males: ISA, ISSAM, and EAU recommendations
- Contraceptive use in acne
- Effects of Intramuscular Testosterone Undecanoate on Body Composition and Bone Mineral Density in Female-to-Male Transsexuals
- FDA declines approval of testosterone drug for third time
- FDA declines approval of testosterone drug for third time
- A Review of Androgen‐Progestin Regimens for Male Contraception
- The latest options and future agents for treating male hypogonadism
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →